Report on Unsupported Price Increases regarding Roche’s Rituxan® released

Oct 8, 2019

The Institute for Clinical and Economic Review releases its report on Unsupported Price Increases, highlighting Roche’s Rituxan® as one of the products with price increases which are unsupported by new clinical evidence. 

Print Page Mail Article